2.4. Analysis.
Comparison 2: Exenatide vs no treatment (14 months (60.8 weeks) post baseline), Outcome 4: Adverse events ‐ weight loss (kg) (assessed at 12 months (52 weeks))
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.